Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study

被引:107
作者
Kroon, FP
van Dissel, JT
de Jong, JC
Zwinderman, K
van Furth, R
机构
[1] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 Leiden, Netherlands
[2] Natl Inst Publ Hlth & Environm, Virol Lab, NL-3720 BA Bilthoven, Netherlands
[3] Leiden Univ, Dept Med Stat, NL-2300 Leiden, Netherlands
关键词
annual influenza vaccination; HIV-infection; CD4(+) T-lymphocytes;
D O I
10.1016/S0264-410X(00)00079-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In a consecutive 3-year study the antibody response after immunization with influenza vaccine of a cohort of HIV-infected adults was studied. The haemagglutination-inhibiting (HAI) antibody titres after vaccination correlated with the number of CD4(+) T lymphocytes (p < 0.001), the prevaccination antibody titres (p < 0.001), and the proliferative response to anti-CD3 (p < 0.001). Severely impaired antibody responses were observed in HIV-infected individuals with CD4(+) T-lymphocyte counts less than or equal to 100 x 10(6)/l. Significantly higher prevaccination antibody titres were observed in healthy controls in the 2nd or 3rd year of vaccination, but not in HIV-infected individuals. Annually repeated vaccination of HIV-infected individuals did not lead to higher postvaccination antibody titres. Annual vaccination of HIV-infected individuals with CD4(+) T-lymphocyte counts exceeding 100 x 10(6)/l seems to be worthwhile, although it may not be expected to render the same level of protection against influenza as in non-infected individuals. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3040 / 3049
页数:10
相关论文
共 50 条
[1]  
AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447
[2]  
BALLET JJ, 1987, CLIN EXP IMMUNOL, V68, P479
[3]   Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults [J].
Beyer, WEP ;
Palache, AM ;
Sprenger, MJW ;
Hendriksen, E ;
Tukker, JJ ;
Darioli, R ;
vanderWater, GL ;
Masurel, N ;
Osterhaus, ADME .
VACCINE, 1996, 14 (14) :1331-1339
[4]   EFFECT OF IMMUNOMODULATOR THYMOPENTIN ON IMPAIRED SERORESPONSE TO INFLUENZA VACCINE IN PATIENTS ON HEMODIALYSIS [J].
BEYER, WEP ;
NOORDZIJ, TC ;
KRAMER, P ;
DIDERICH, PPMN ;
DENHOEK, CTO ;
JANSSEN, J ;
MASUREL, N ;
WEIMAR, W .
NEPHRON, 1990, 54 (04) :296-301
[5]  
BEYER WEP, 1998, IN PRESS ARCH INTERN
[6]   WHOLE-BLOOD LYMPHOCYTE-CULTURES [J].
BLOEMENA, E ;
ROOS, MTL ;
VANHEIJST, JLAM ;
VOSSEN, JMJJ ;
SCHELLEKENS, PTA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 122 (02) :161-167
[7]  
BRODER S, 1994, TXB AIDS MED, pCH5
[8]  
*CDC, 1992, MMWR, V41
[9]   SUSCEPTIBILITY TO INFLUENZA-A IN HIV-POSITIVE PATIENTS [J].
COHEN, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (02) :245-245
[10]   NATURAL OR VACCINE-INDUCED ANTIBODY AS A PREDICTOR OF IMMUNITY IN THE FACE OF NATURAL CHALLENGE WITH INFLUENZA-VIRUSES [J].
DAVIES, JR ;
GRILLI, EA .
EPIDEMIOLOGY AND INFECTION, 1989, 102 (02) :325-333